Applied Therapeutics, Inc. Current Liabilities
Applied Therapeutics, Inc. had Current Liabilities of $32.90 million as of 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2025-11-13
- 2025-09-30: Liabilities, Current $32.90M.
- 2025-06-30: Liabilities, Current $17.75M.
- 2025-03-31: Liabilities, Current $17.96M.
- 2024-12-31: Liabilities, Current $27.30M.
| Period end | Liabilities, Current |
|---|---|
| 2025-09-30 | $32.90M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $17.75M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $17.96M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $27.30M 10-Q · filed 2025-11-13 |
| 2024-09-30 | $98.97M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $55.36M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $83.91M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $71.18M 10-K · filed 2025-04-15 |
| 2023-09-30 | $55.50M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $47.19M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $33.25M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $33.42M 10-K · filed 2024-03-06 |
| 2022-09-30 | $46.51M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $51.72M 10-Q · filed 2022-08-12 |
| 2022-03-31 | $22.22M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $26.46M 10-K · filed 2023-03-23 |
| 2021-09-30 | $30.84M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $23.41M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $19.77M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $21.23M 10-K · filed 2022-03-10 |
| 2020-09-30 | $20.50M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $18.88M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $8.47M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $14.10M 10-K · filed 2021-03-18 |
| 2019-09-30 | $6.52M 10-Q · filed 2019-11-13 |
| 2019-06-30 | $6.78M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $6.33M 10-Q · filed 2019-06-21 |
| 2018-12-31 | $4.43M 10-K · filed 2020-03-13 |